
SEMA-2
Prefilled Klik-Pen
Semaglutide is a GLP-1 receptor agonist researched for glucose homeostasis and weight management, delivered in a once-weekly prefilled Klik-pen.
Modified GLP-1(7-37) analogueKLIKZEMPIC contains semaglutide, a long-acting GLP-1 receptor agonist with 94% structural homology to native GLP-1. Each pen contains 8mg/3ml (4 doses of 2mg). An amino acid substitution at position 8 and a C-18 fatty di-acid chain enable albumin binding, extending the half-life to approximately 7 days. Research focuses on glycemic control, appetite regulation, cardiovascular risk reduction, and neuroinflammation pathways.
All products are sold strictly for research and laboratory use only. Not for human consumption. By purchasing, you agree to use these products only for legitimate research purposes.